𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of adenovirus immobilization strategies for in situ gene therapy

✍ Scribed by Wei-Wen Hu; Michael W. Lang; Paul H. Krebsbach


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
280 KB
Volume
10
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Regenerative gene therapy using viral vectors enables transduced cells to express bioactive factors in vivo. Viral delivery with spatial control can enhance transduction efficiency and may limit systemic infection. Consequently, we tethered biotinylated adenovirus via interactions with avidin on chitosan surfaces to gain robust control for in situ transduction.

Methods

Avidin was either directly conjugated to chitosan (virus–biotin–avidin‐material; VBAM) or indirectly docked on biotinylated chitosan surfaces (virus–biotin–avidin–biotin‐material; VBABM) to tether biotinylated adenovirus. Enzyme‐linked immunosorbent assay (ELISA) and spectroscopic analysis were performed to demonstrate the binding profiles. Biotin‐alkaline phosphatase and biotinylated adenovirus were used as different sized particles to evaluate binding efficiencies and were compared by the Sips isotherm adsorption method. Scanning electron microscopy (SEM) examination illustrated virus distribution, and the transduction efficiency was determined by in vitro cell transduction.

Results

ELISA and spectroscopic analysis both demonstrated that the VBAM system led to multilayer avidin formation on biomaterial surfaces, whereas VBABM formed a monolayer of avidin. Sips isotherm adsorption indicated that the VBAM method increased heterogeneity and steric hindrance of binding sites. By contrast, the VBABM method docked avidin on chitosan surfaces and orientated the binding sites to facilitate ligand binding. In addition, SEM images illustrated that the VBABM method led to more even viral distribution. In vitro cell infection experiments also demonstrated that the VBABM system enhanced virus immobilization and thus improved cell transduction efficiency over the VBAM system.

Conclusions

The VBABM strategy is a superior method for in situ transduction from biomaterials. This strategy could be adapted for use with a variety of biomaterials as well as viral vectors, and thus may be an alternative method for in vivo regenerative gene therapy. Copyright © 2008 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Development of gene therapy-based strate
✍ Piroska E. Rakoczy; Wei-Yong Shen; May Lai; Fabienne Rolling; Ian J. Constable 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from

In situ generation of pseudotyped retrov
✍ Takashi Okada; Natasha J. Caplen; W. Jay Ramsey; Masafumi Onodera; Kuniko Shimaz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

## Abstract ## Background Hybrid adeno‐retroviral vector systems utilize the high efficiency of adenovirus transduction to direct the __in situ__ production of retroviral progeny. In this study, we show that a single‐step transduction of glioma cells with trans‐complementing hybrid adeno‐retrovira

Widespread gene transduction to the cent
✍ Jin-Song Shen; Xing-Li Meng; Hiroshi Maeda; Toya Ohashi; Yoshikatsu Eto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract ## Background In some lysosomal storage diseases, considerable alterations of the central nervous system (CNS) occur prior to birth and neurodegeneration progresses rapidly soon after birth causing early death in patients. No effective treatment is available after birth. Treatment may

Inter-patient variation in efficacy of f
✍ John T. Lam; Anna Kanerva; Gerd J. Bauerschmitz; Koichi Takayama; Kaori Suzuki; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

## Abstract ## Background Gene therapy offers a new strategy for cancer treatment. Adenoviruses represent the most widely used gene therapy vector and feature an excellent safety record. Conditionally replicative adenoviruses (CRAds) effect solid tumor penetration and tumor selective oncolysis and